Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX crawled time : 11:00 save search
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Published: 2024-03-07 (Crawled : 11:00) - prnewswire.com
AMLX | $1.96 -1.01% 430K
|
|
| O: -0.68%
H: 1.37%
C: 0.26%
INMD | $17.225 -0.66% 280K
|
Health Technology
|
| O: 0.88%
H: 0.52%
C: -1.26%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
Shareholders that lost money on BioNTech SE (BNTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Published: 2024-02-23 (Crawled : 11:00) - prnewswire.com
AMPL | $9.42 -0.42% 55K
|
|
| O: 1.44%
H: 1.0%
C: 0.75%
INMD | $17.225 -0.66% 280K
|
Health Technology
|
| O: -0.34%
H: 3.83%
C: 3.54%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.74%
H: 0.66%
C: -0.31%
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) Shareholders
Published: 2024-02-09 (Crawled : 11:00) - prnewswire.com
ON | $61.4 -2.43% 3.1M
|
Electronic Technology
|
| O: 0.84%
H: 0.25%
C: -0.72%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -0.91%
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.16%
H: 0.17%
C: -1.16%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 2.85%
H: 0.0%
C: -7.69%
pipeline cell collaboration car-t therapy
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -0.39%
H: 2.48%
C: 1.8%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.99%
H: 1.81%
C: 0.47%
covid-19 vaccine positive influenza topline program
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
Published: 2023-10-23 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
day report innovation update series financial results
BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication
Published: 2023-10-19 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.4%
H: 0.4%
C: -0.81%
cancer immunotherapy trial
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate
Published: 2023-10-12 (Crawled : 11:00) - prnewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -1.01%
H: 0.17%
C: -0.83%
license worldwide collaboration therapeutics agreement
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
Published: 2023-09-18 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -3.56%
partnership vaccine mrna 100
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
Published: 2023-08-14 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 1.38%
H: 0.92%
C: 0.59%
management
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
Published: 2023-07-24 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 1.05%
H: 0.08%
C: -1.45%
report update financial results
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
Published: 2023-06-29 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.33%
H: 1.5%
C: 0.42%
bnt316 program trial
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
Published: 2023-06-02 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 3.21%
H: 2.0%
C: 0.62%
bnt316 candidate antibody asco positive
CureVac gibt Entwicklungen im Patentrechtsstreit mit Pfizer/BioNTech bekannt
Published: 2023-05-19 (Crawled : 11:00) - curevac.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.67%
H: 1.53%
C: 0.28%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.14%
H: 1.45%
C: 1.28%
CVAC | News | $2.41 -1.23% 190K
|
Health Technology
|
| O: 0.91%
H: 4.53%
C: 2.49%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.37%
H: 1.96%
C: 1.09%
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.1%
H: 0.52%
C: 0.36%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
update financial results
Arbutus Reports First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-04 (Crawled : 11:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.1%
H: 0.85%
C: -2.15%
ABUS | News | $2.705 -0.92% 300K
|
Health Technology
|
| O: -0.4%
H: 2.8%
C: 2.0%
update financial results
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Update on May 10, 2023
Published: 2023-05-03 (Crawled : 11:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.97%
H: 1.1%
C: 0.13%
MTNB | $0.1913 0.68% 190K
|
Health Technology
|
| O: -0.6%
H: 4.17%
C: -1.47%
conference business update biopharma financial results
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
Published: 2023-04-24 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -3.75%
H: 3.13%
C: 2.71%
report update financial results
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.